ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, R
Right arrow Articles by Warner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, R
Right arrow Articles by Warner, J.
Eur Respir J 1999; 13: 87-94
Copyright © ERS Journals Ltd 1999

Clinical Trial

Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone

R Rao, RK Gregson, AC Jones, EA Miles, MJ Campbell, and JO Warner

Inhaled steroids are frequently used in childhood asthma, but concerns based on limited objective evidence remain, regarding long-term side-effects. In this study the systemic effects of standard doses of inhaled steroids in childhood asthma were assessed, comparing beclomethasone dipropionate (BDP) with fluticasone propionate (FP). The study was prospective, randomized and double-blind. Twenty-three steroid-naive children with moderately severe asthma, aged 5-10 yrs, were allocated either BDP (400 microg x day(-1) or FP (200 microg x day(-1)) using a metered-dose inhaler with a spacer. Asthma control was assessed at regular intervals over 20 months. Fasting morning blood and overnight urine samples were collected for estimation of serum cortisol, serum 1-carboxyterminal telopeptide (ICTP), serum osteocalcin and urine deoxypyridinoline (DPD). Bone mineral density (BMD) was measured at each visit. None of the markers of bone turnover showed any change during the study period. BMD increased at normal rates with age. Serum cortisol significantly decreased on BDP, but not on FP. A significant difference in growth rates was found between the groups, with a slower rate of growth towards the end of the observation period in the BDP group. In conclusion when taken in a relatively modest dose over a period of time, beclomethasone dipropionate had significant effects on the hypothalamic-pituitary-adrenal axis and statural growth in childhood asthma. These systemic effects were not seen with an equipotent dose of fluticasone propionate.


This article has been cited by other articles:


Home page
 PediatricsHome page
H. W. Kelly, M. L. Van Natta, R. A. Covar, J. Tonascia, R. P. Green, R. C. Strunk, and for the CAMP Research Group
Effect of Long-term Corticosteroid Use on Bone Mineral Density in Children: A Prospective Longitudinal Assessment in the Childhood Asthma Management Program (CAMP) Study
Pediatrics, July 1, 2008; 122(1): e53 - e61.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
B. Q. Lanier
Use of Intranasal Corticosteroids in the Management of Congestion and Sleep Disturbance in Pediatric Patients With Allergic Rhinitis
Clinical Pediatrics, June 1, 2008; 47(5): 435 - 445.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
M.J. Visser, E. van der Veer, D.S. Postma, L.R. Arends, T.W. de Vries, P.L.P. Brand, and E.J. Duiverman
Side-effects of fluticasone in asthmatic children: no effects after dose reduction
Eur. Respir. J., September 1, 2004; 24(3): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. T. Leone, J. E. Fish, S. J. Szefler, and S. L. West
Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology
Chest, December 1, 2003; 124(6): 2329 - 2340.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. Roux, S. Kolta, J.-L. Desfougeres, P. Minini, and E. Bidat
Long-Term Safety of Fluticasone Propionate and Nedocromil Sodium on Bone in Children With Asthma
Pediatrics, June 1, 2003; 111(6): e706 - 713.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Devoy
Use of inhaled corticosteroids in children
Arch. Dis. Child., May 1, 2003; 88(5): 461 - 461.
[Full Text]

Home page
 Arch. Dis. Child.Home page
G Russell
Inhaled corticosteroids and adrenal insufficiency
Arch. Dis. Child., December 1, 2002; 87(6): 455 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K-H. Carlsen and J. Gerritsen
Inhaled steroids in children: adrenal suppression and growth impairment
Eur. Respir. J., June 1, 2002; 19(6): 985 - 988.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
F. M. de Benedictis, A. Teper, R. J. Green, A. L. Boner, L. Williams, H. Medley, and for the International Study Group
Effects of 2 Inhaled Corticosteroids on Growth: Results of a Randomized Controlled Trial
Arch Pediatr Adolesc Med, November 1, 2001; 155(11): 1248 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. PEDERSEN
Do Inhaled Corticosteroids Inhibit Growth in Children?
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 521 - 535.
[Full Text] [PDF]

Home page
 DTBHome page
The use of inhaled corticosteroids in childhood asthma
DTB, October 1, 1999; 37(10): 73 - 77.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.